The largest database of trusted experimental protocols

31 protocols using tnf α

1

Antioxidant Effects on Oxidative Stress

Check if the same lab product or an alternative is used in the 5 most similar protocols
NIH3T3 and HeLaS3 cells were cultured at 37°C in a 5% CO2 atmosphere in Dulbecco's modified Eagle's medium (DMEM; Sigma) supplemented with 10% fetal bovine serum, 100 units/ml penicillin, and 100 mg/ml streptomycin.
Cells were stimulated with 25 mM H2O2 (WAKO, Japan) for 20 min or 10 ng/ml TNFα (WAKO) for 5 h. The antioxidants applied in this study included N-acetyl-l-cysteine (NAC; WAKO) and l(+)-ascorbic acid (WAKO). NAC at various concentrations (2.5, 25, 250, 2500 µM) or ascorbic acid (0.1, 1, 10, 100 µM) was added to the culture medium at 4 h after E50K transfection. Afterwards, every 12 h, the medium was replaced with new medium containing antioxidants. E50K-expressing cells, without any treatment, but with medium replacement, were used as a control.
+ Open protocol
+ Expand
2

Bovine Chondrocyte Culture and Cytokine Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chondrocytes were isolated from articular cartilage of the MTP joints of 10-month-old bovine by digestion with 0.08% collagenase (Wako Pure Chemical Industries, Osaka, Japan) for 6 h at 37°C. After filtration, cells were cultured in Dulbecco’s modified Eagle’s medium (Gibco, Grand Island, NY, USA) supplemented with 200 U/mL of penicillin, 40 g/mL of streptomycin, and 10% fetal bovine serum at 37°C in a humidified hypoxic atmosphere (5% O2 and CO2). Cells were seeded at a density of 2×104 in 35 mm plates and cultured in a monolayer until confluence and for 96 h thereafter. The cells were allocated into eight groups (groups A-H) and treated with various reagents when they reached confluence. Cells assigned to group A were treated with phosphate buffered saline. Group B was treated with 0.1 ng/mL interleukin-1β (IL-1β); group C was treated with 1.0 ng/mL IL-1β; group D was treated with 10 ng/mL IL-1β; group E was treated with 1.0 ng/mL tumor necrosis factor-alpha (TNF-α); group F was treated with 10 ng/mL TNF-α; group G was treated with 100 ng/mL TNF-α and group H (control) was cultured without adding any agents. IL-1β and TNF-α were purchased from Wako Pure Chemical Industries (Osaka, Japan).
+ Open protocol
+ Expand
3

Cytokine Array Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
A cytokine array analysis (R&D system, Cat# ARY005) was performed according to the manufacturer's instructions. The concentration of each cytokine for stimulation was as follows: IFN-γ (Wako), 20 ng/ml; TNF-α (Wako), 20 ng/ml and IL-10 (Wako), 50 ng/ml [40 (link)]. The experiments for each stimulation were repeated at least twice, and similar results were obtained.
+ Open protocol
+ Expand
4

Islet Cell Death Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Islets isolated from wild-type and Oxtr−/− mice were isolated and cultured in RPMI medium supplemented with 5% FBS overnight. Subsequently, only size-matched and well-shaped islets were transferred to a 12-well plate (20 islets/well), with each well represents one replicate. The islets were treated with 100 pM OXT (Sigma), 1 nM AVP (Sigma), 2 ng/mL Tunicamycin (Sigmga-Aldrich), or a cytokine mixture [IL1-β (50 U/mL) •TNF-α (1 × 103 U/mL) •INF-α (1 × 103 U/mL), Wako] for 24 hours. Cell death was measured by the Cell Death Detection ELISA Assay Kit (Roche) according to the manufacturer’s protocol. The cell death level was measured as the absorbance at 405 nm with respect to a substrate solution blank. The experiment was repeated for three times. The n number represents the total number of replicates from these independent experiments.
+ Open protocol
+ Expand
5

Modulating Monocyte Adhesion to Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To prepare soft or stiff endothelial cells, HUVECs were treated with 10 μM of blebbistatin (Merck Millipore, Darmstadt, Germany) or 1 μM of carbenoxolone (Sigma). They were then stimulated by tumor necrosis factor-α (TNF-α) (10 units/mL, FUJIFILM Wako, Osaka, Japan) for 4 h. THP-1 cells were stained with calcein-AM and co-cultured with HUVECs for 1 h. After incubation, to remove non-adhesive cells, HUVECs were washed twice with PBS. THP-1 cells bound to HUVECs were counted using an Olympus IX71 fluorescence microscope.
To assess the effect of rsTM-mediated cellular softening on monocyte adhesion, HUVECs were treated with rsTM (0, 1, 3, 10 μg/mL) in the presence or absence of LPS (1 μg/mL) for 4 h. HUVECs were washed twice with PBS and then cocultured with HUVECs for 1 h. After incubation, to remove non-adhesive cells, HUVECs were washed twice with PBS. THP-1 cells bound to HUVECs were observed under an Olympus IX71 fluorescence microscope. Quantification of the THP-1 cells that had adhered to HUVECs was performed using ImageJ 1.53a software.
+ Open protocol
+ Expand
6

Serum Biomarker Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum was obtained by centrifugation at 1500×g for 15 min at 4 °C. The serum levels of total cholesterol, high-density lipoprotein (HDL)-cholesterol, triglyceride, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were analyzed using a Hitachi 7060 Automatic Analyzer (Hitachi, Tokyo, Japan) with commercial kits (Fujifilm Wako Pure Chemical Co., Osaka, Japan). The serum insulin (Morinaga Institute of Biological Science, Yokohama, Japan), adiponectin (Otsuka Pharmaceutical Co. Ltd. Tokyo, Japan), tumor necrosis factor-α (TNF-α; Fujifilm Wako Pure Chemical Co., Osaka, Japan), and monocyte chemoattractant protein-1 (MCP-1; Proteintech, Rosemont, IL, USA) levels were also determined using a commercial ELISA kit. Serum malondialdehyde (MDA) levels were determined using a commercial kit (Japan Institute for the Control of Aging Co. Ltd., Shizuoka, Japan). The homeostasis model assessment insulin resistance (HOMA-IR), an insulin resistance index, was calculated using the following equation: HOMA-IR = fasting glucose (mg/dL) × fasting insulin (ng/mL)/22.5.
+ Open protocol
+ Expand
7

Cytokine-Induced Transcriptional Changes in Islets

Check if the same lab product or an alternative is used in the 5 most similar protocols
MIN6 cells or islets were incubated with a cytokine cocktail (DMEM containing 5 ng/mL IL-1β (Fujifilm Wako Pure Chemical Co.), 10 ng/mL TNF-α (Fujifilm Wako Pure Chemical Co.) and 50 ng/mL IFN-γ (Fujifilm Wako Pure Chemical Co.) for 4 h to induce cytokine production within islets (defined as “CC”). The groups incubated with MCC950 (10 µM) or not treated were defined as “CC + MCC950” and “control”, respectively. After treatments, MIN6 cells or islets were lysed with TRIzol Reagent (Thermo Fisher Scientific) and RNA was extracted from lysates using the PureLink RNA Mini Kit (Thermo Fisher Scientific). RNA was reverse transcribed using the High-Capacity cDNA Reverse Transcription Kit (Thermo Fisher Scientific). Quantitative real-time PCR for cDNA was performed using the LightCycler96 System (Roche) with TB Green Premix Ex Ta II (Takara Bio Inc., Shiga, Japan) for amplification and detection. The expressions of Il1b and Nlrp3 were normalized to the expression of Rplp0. The primers were as follows: 5′-TCCAGGATGAGGACATGAGCAC-3′ (forward) and 5′-GAACGTCACACACCAGCAGGTTA-3′ (reverse) for Il1b, 5′-AATGCCCTTGGAGACACAGGA-3′ (forward) and 5′-TGAGGTGAGGCTGCAGTTGTCTA-3′ (reverse) for Nlrp3, 5′-GGCAGCATTTATAACCCTGAAGTG-3′ (forward) and 5′-TGTACCCATTGATGATGGAGTGTG-3′ (reverse) for Rplp0.
+ Open protocol
+ Expand
8

Caspase-8 Activation in TNF-α-Induced Apoptosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were pretreated with 10 μM Z-VAD-FMK (Peptide Institute) for 1 h and then stimulated with 10 ng/ml TNF-α (Wako Chemicals) and 20 μg/ml CHX (Calbiochem) for the indicated times. Cells were then lysed with lysis buffer (30 mM Tris-HCl [pH 7.5], 120 mM NaCl, 1% Triton X-100, 10% glycerol, 2 mM PMSF, 2 mM EDTA, 2 mM imidazole, and 10 mM NaF), followed by centrifugation at 20,000 × g for 20 min at 4°C. The cleared lysates were immunoprecipitated with an anti-caspase-8 antibody and Dynabeads protein A. Immunoprecipitants were analyzed by immunoblotting.
+ Open protocol
+ Expand
9

NF-κB Luciferase Reporter Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were transfected with the luciferase reporter plasmid pGL4.32[luc2P/NF-κB-RE/Hygro] (Promega, Madison, WI, USA), and stably expressing cells were selected with hygromycin. Before the luciferase assay, cells were plated on 96-well plates at a density of 1.5 × 104 cells/well and cultured in DMEM for 24 h. The cells were then treated with 20 ng/mL of TNF-α (Wako, Osaka, Japan) for 5 h. Luciferase activity was measured by using the Nano-Glo Dual-Luciferase Reporter Assay System (Promega). Each experiment was independently conducted three times, with five replicates for each sample.
+ Open protocol
+ Expand
10

Cytokine and Myokine Effects on HUVECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUVECs (C2519A) were purchased from Lonza Japan (Tokyo, Japan). Cells were cultured in EGM-2 Endothelial Cell Growth Medium-2 BulletKit (CC-3162, Lonza Japan). The cells were used between passages 4 and 6. All experiments were carried out with the same batch of HUVECs, which were from pooled donors. HUVECs were incubated with TNFα (10 ng/mL) (203–15263, Wako Pure Chemical Industries, Ltd., Osaka, Japan), Irisin (5 nM) (067–29, Phoenix Pharmaceuticals, Inc., Burlingame, CA, USA), and BAIBA (10 µM) (A0324, Tokyo Chemical Industry Co., Ltd., Tokyo, Japan) for 24 hours. After incubation, total RNA was extracted using 200 μL RNA iso plus. Reverse transcription and qPCR protocols are described above.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!